252 related articles for article (PubMed ID: 7525826)
1. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment.
Miell JP; Buchanan CR; Norman MR; Maheshwari HG; Blum WF
J Endocrinol; 1994 Sep; 142(3):547-54. PubMed ID: 7525826
[TBL] [Abstract][Full Text] [Related]
2. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers.
Miell JP; Taylor AM; Jones J; Holly JM; Gaillard RC; Pralong FP; Ross RJ; Blum WF
J Endocrinol; 1993 Mar; 136(3):525-33. PubMed ID: 7682595
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
[TBL] [Abstract][Full Text] [Related]
4. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO
Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study.
Jørgensen JO; Pedersen SB; Børglum J; Frystyk J; Ho KK; Christiansen JS; Orskov H; Blum WF; Richelsen B
Eur J Endocrinol; 1995 Jul; 133(1):65-70. PubMed ID: 7542982
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
[TBL] [Abstract][Full Text] [Related]
8. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
Juul A; Main K; Blum WF; Lindholm J; Ranke MB; Skakkebaek NE
Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
[TBL] [Abstract][Full Text] [Related]
9. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
[TBL] [Abstract][Full Text] [Related]
10. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency.
Bang P; Brandt J; Degerblad M; Enberg G; Kaijser L; Thorén M; Hall K
Eur J Clin Invest; 1990 Jun; 20(3):285-92. PubMed ID: 1695151
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Blum WF; Hall K; Ranke MB; Wilton P
Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
[TBL] [Abstract][Full Text] [Related]
13. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
14. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
[TBL] [Abstract][Full Text] [Related]
16. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats.
Ramos S; Goya L; Alvarez C; Martín MA; Pascual-Leone AM
J Endocrinol; 2001 Apr; 169(1):111-22. PubMed ID: 11250652
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
Laursen T; Jørgensen JO; Christiansen JS
Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
[TBL] [Abstract][Full Text] [Related]
18. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
[TBL] [Abstract][Full Text] [Related]
20. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]